| Oscar Coppes, | |
|
1155 N Mayfair Rd, Wauwatosa, WI 53226-3462 | |
| (414) 955-7199 | |
| (414) 955-0110 |
| Full Name | Oscar Coppes |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 10 Years |
| Location | 1155 N Mayfair Rd, Wauwatosa, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821408725 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 036149789 (Illinois) | Secondary |
| 207LP2900X | Anesthesiology - Pain Medicine | 80115 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Froedtert Memorial Lutheran Hospital | Milwaukee, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Medical College Of Wisconsin Inc | 2668384371 | 1813 |
News Archive
MasterControl, a global provider of software solutions that enable regulated companies to improve internal efficiency and reduce overall costs while accelerating time to market, announced today that the company and i4DM, a MasterControl partner, have been selected as the software provider and implementation team of a quality management system (QMS) for the Food and Drug Administration (FDA).
Scientists report a remarkable improvement in Alzheimer's transgenic mice following treatment with a new drug. The study, published by Cell Press in the July 10th issue of the journal Neuron, provides the first demonstration that an ionophore, a compound that transports metal ions across cell membranes, can elicit rapid and pronounced improvement in neuropathology and cognitive function in mouse models of Alzheimer's Disease (AD).
More than 3.2 million Americans suffer from schizophrenia; about 100,000 people are newly diagnosed every year. The disease includes a wide range of symptoms including visual and auditory hallucinations, cognitive problems and motivational issues.
The bacterium that causes Legionnaires' disease remains difficult to track. French researchers have now developed a new technique that should allow living representatives of this dangerous pathogen to be detected much more quickly than with conventional methods. As they report in the journal Angewandte Chemie, samples are exposed to an azide-modified compound that the pathogen specifically incorporates into its shell, which is made of saccharide units. A fluorescent marker attached to the azide groups is used to identify the pathogen.
Difficulties with healthcare.gov and questions about the contractors that built it will be high on the list of issues receiving scrutiny.
› Verified 4 days ago
| Entity Name | The Medical College Of Wisconsin Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699720086 PECOS PAC ID: 2668384371 Enrollment ID: O20031120000259 |
News Archive
MasterControl, a global provider of software solutions that enable regulated companies to improve internal efficiency and reduce overall costs while accelerating time to market, announced today that the company and i4DM, a MasterControl partner, have been selected as the software provider and implementation team of a quality management system (QMS) for the Food and Drug Administration (FDA).
Scientists report a remarkable improvement in Alzheimer's transgenic mice following treatment with a new drug. The study, published by Cell Press in the July 10th issue of the journal Neuron, provides the first demonstration that an ionophore, a compound that transports metal ions across cell membranes, can elicit rapid and pronounced improvement in neuropathology and cognitive function in mouse models of Alzheimer's Disease (AD).
More than 3.2 million Americans suffer from schizophrenia; about 100,000 people are newly diagnosed every year. The disease includes a wide range of symptoms including visual and auditory hallucinations, cognitive problems and motivational issues.
The bacterium that causes Legionnaires' disease remains difficult to track. French researchers have now developed a new technique that should allow living representatives of this dangerous pathogen to be detected much more quickly than with conventional methods. As they report in the journal Angewandte Chemie, samples are exposed to an azide-modified compound that the pathogen specifically incorporates into its shell, which is made of saccharide units. A fluorescent marker attached to the azide groups is used to identify the pathogen.
Difficulties with healthcare.gov and questions about the contractors that built it will be high on the list of issues receiving scrutiny.
› Verified 4 days ago
| Entity Name | Froedtert &the Medical College Of Wisconsin Community Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568787448 PECOS PAC ID: 3678760063 Enrollment ID: O20101210000699 |
News Archive
MasterControl, a global provider of software solutions that enable regulated companies to improve internal efficiency and reduce overall costs while accelerating time to market, announced today that the company and i4DM, a MasterControl partner, have been selected as the software provider and implementation team of a quality management system (QMS) for the Food and Drug Administration (FDA).
Scientists report a remarkable improvement in Alzheimer's transgenic mice following treatment with a new drug. The study, published by Cell Press in the July 10th issue of the journal Neuron, provides the first demonstration that an ionophore, a compound that transports metal ions across cell membranes, can elicit rapid and pronounced improvement in neuropathology and cognitive function in mouse models of Alzheimer's Disease (AD).
More than 3.2 million Americans suffer from schizophrenia; about 100,000 people are newly diagnosed every year. The disease includes a wide range of symptoms including visual and auditory hallucinations, cognitive problems and motivational issues.
The bacterium that causes Legionnaires' disease remains difficult to track. French researchers have now developed a new technique that should allow living representatives of this dangerous pathogen to be detected much more quickly than with conventional methods. As they report in the journal Angewandte Chemie, samples are exposed to an azide-modified compound that the pathogen specifically incorporates into its shell, which is made of saccharide units. A fluorescent marker attached to the azide groups is used to identify the pathogen.
Difficulties with healthcare.gov and questions about the contractors that built it will be high on the list of issues receiving scrutiny.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Oscar Coppes, 1155 N Mayfair Rd, Wauwatosa, WI 53226-3462 Ph: (414) 955-7199 | Oscar Coppes, 1155 N Mayfair Rd, Wauwatosa, WI 53226-3462 Ph: (414) 955-7199 |
News Archive
MasterControl, a global provider of software solutions that enable regulated companies to improve internal efficiency and reduce overall costs while accelerating time to market, announced today that the company and i4DM, a MasterControl partner, have been selected as the software provider and implementation team of a quality management system (QMS) for the Food and Drug Administration (FDA).
Scientists report a remarkable improvement in Alzheimer's transgenic mice following treatment with a new drug. The study, published by Cell Press in the July 10th issue of the journal Neuron, provides the first demonstration that an ionophore, a compound that transports metal ions across cell membranes, can elicit rapid and pronounced improvement in neuropathology and cognitive function in mouse models of Alzheimer's Disease (AD).
More than 3.2 million Americans suffer from schizophrenia; about 100,000 people are newly diagnosed every year. The disease includes a wide range of symptoms including visual and auditory hallucinations, cognitive problems and motivational issues.
The bacterium that causes Legionnaires' disease remains difficult to track. French researchers have now developed a new technique that should allow living representatives of this dangerous pathogen to be detected much more quickly than with conventional methods. As they report in the journal Angewandte Chemie, samples are exposed to an azide-modified compound that the pathogen specifically incorporates into its shell, which is made of saccharide units. A fluorescent marker attached to the azide groups is used to identify the pathogen.
Difficulties with healthcare.gov and questions about the contractors that built it will be high on the list of issues receiving scrutiny.
› Verified 4 days ago
Craig R Cook, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4025 N 92nd St, Wauwatosa, WI 53222 Phone: 414-358-5431 Fax: 414-358-5421 | |
William Jonathan Wood, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2643 N 113th St, Wauwatosa, WI 53226 Phone: 414-526-9683 | |
Maryam K Doyle, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 10900 W Potter Rd, Wauwatosa, WI 53226 Phone: 414-774-9227 | |
Theresa M Richter, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 10900 W Potter Rd, Wauwatosa, WI 53226 Phone: 262-787-6737 Fax: 262-782-6040 | |
Omar Dyara, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 959 N Mayfair Rd, Wauwatosa, WI 53226 Phone: 414-955-3955 | |
Dr. Shibani Bhattacharyya, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 11152 W Meinecke Ave, Apt #2, Wauwatosa, WI 53226 Phone: 804-878-0278 | |
Khalid Ghazi Al Abdul Raheem, B.S Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4025 N 92nd St, Wauwatosa, WI 53222 Phone: 414-358-5431 |